Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Favipiravir in Uncomplicated Influenza
NCT02026349Phase 3Completed
- Sponsor
- MDVI, LLC
- Start
- Jan 2014
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of favipiravir in influenza, sponsored by MDVI, LLC. Started Jan 2014; status: completed.
02
Drugs
favipiravir
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02026349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02026349.